IEEE Spectrum on MSN4h
New Brain Tech Gives Voice to ALS PatientsA myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Study Finds on MSN1d
Researchers uncover serious flaw in promising Alzheimer’s blood testsNew research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...
A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease progression.
ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...
Despite being diagnosed with Amyotrophic Lateral Sclerosis, or ALS, a longtime coach at Northern Bedford County High School ...
StudyFinds on MSN9d
Breakthrough blood test could transform ALS diagnosis, careFind out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
The early diagnosis of Alzheimer’s disease (AD) through the detection of p-tau proteins in the blood is less disease-specific ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback